| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 11,548 | 12,757 | 12,630 | 14,615 | | Cost of Revenue | 9,612 | 11,328 | 10,777 | 14,339 | | | Gross Profit | 1,936 | 1,429 | 1,853 | 276 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,652 | 2,349 | 2,825 | 3,343 | | Non Recurring |
-
| (18) | 18 | (2) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (661) | (902) | (990) | (3,065) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 61 | 29 | 20 | (751) | | Earnings Before Interest And Taxes | (655) | (873) | (970) | (3,816) | | Interest Expense | 220 | 402 | 491 | (265) | | Income Before Tax | (875) | (1,275) | (1,461) | (3,551) | | Income Tax Expense |
-
|
-
|
-
| 77 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (875) | (1,275) | (1,461) | (3,628) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (875) | (1,275) | (1,461) | (3,628) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($875) | ($1,275) | ($1,461) | ($3,628) |
|
0.02% Nasdaq 
0.0025 (3.57%) 
Income Statement
